San Francisco startup Construction Therapeutics is usually focusing on an oral, at the time-daily GLP-1 drug named GSBR-1290—the drug surpassed Wall Street’s expectations in June whenever a mid-stage review showed common weight loss of all around 6% and it ideas to start An additiona